SCHEMBL16004255

SCHEMBL16004255

O=S(=O)(c1ccc(Cl)s1)N1CCOc2ccc(COCc3cccc(F)c3)cc2C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
LMNA P02545 4/20 0.41
MAPK1 P28482 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
GPR142 Q7Z601 1/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
RORC P51449 1/20 0.36
PKM P14618 2/20 0.36
PKLR P30613 1/20 0.36
NTRK1 P04629 3/20 0.36
GAA P10253 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MCOLN3 Q8TDD5 1/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16004262 0.88 L3MBTL1 (0.45) L3MBTL1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL16004017 0.85 PKM (0.44) L3MBTL1LMNAMAPK1SMN1; SMN2GPR142
SCHEMBL16004333 0.83 PKM (0.47) L3MBTL1LMNAMAPK1SMN1; SMN2GPR142
SCHEMBL16004012 0.82 NPC1 (0.41) LMNAMAPK1GPR142KMT2AMEN1
SCHEMBL16004231 0.81 PKM (0.53) LMNASMN1; SMN2KMT2AMEN1RORC
SCHEMBL16004230 0.80 PKM (0.46) L3MBTL1LMNAMAPK1SMN1; SMN2TDP1
SCHEMBL16004259 0.80 TSHR (0.49) LMNAMAPK1SMN1; SMN2KMT2AMEN1
SCHEMBL16004261 0.80 LMNA (0.48) CYP2C19LMNAMAPK1SMN1; SMN2TDP1
SCHEMBL16004336 0.79 PKM (0.52) LMNAMAPK1SMN1; SMN2KMT2AMEN1
SCHEMBL16004331 0.79 PKM (0.47) L3MBTL1MAPK1SMN1; SMN2GPR142RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014133414-A2 HETEROCYCLIC TGR5 BILE ACID RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR THE PRODUCTION AND USE THEREOF АЛЛА ХЕМ ЛЛС (US) 2014-09-04 WO disclosed